Cascade Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-20
Closed -$11.5K – 212
2023
Q1
$11.5K Buy
+20
New +$11.3K 0.01% 209
2022
Q3
– Sell
-20
Closed -$10.9K – 206
2022
Q2
$10.9K Hold
20
– – 0.01% 219
2022
Q1
$11.8K Buy
+20
New +$11.5K 0.01% 237

Other funds holding TMO

Cascade Investment Advisors's TMO Position: Q2 2023 in Review

Cascade Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 20 shares — an estimated $11.5K sold.

Cascade Investment Advisors first reported a position in TMO in Q1 2022 and held it in 3 quarters. The position peaked at $11.8K in Q1 2022. 2,388 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Cascade Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Cascade Investment Advisors sold 20 Thermo Fisher Scientific shares in Q2 2023, an estimated $11.5K.
  • Cascade Investment Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 3 quarters.
  • Cascade Investment Advisors's Thermo Fisher Scientific position peaked at $11.8K in Q1 2022.
  • 2,388 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Cascade Investment Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.